Nico Melzer Selected Research

Tea

1/2019

Accelerated long-term forgetting in focal epilepsies with special consideration given to patients with diagnosed and suspected limbic encephalitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nico Melzer Research Topics

Disease

16	Autoimmune Diseases of the Nervous System 01/2024 - 04/2016
11	Multiple Sclerosis 01/2024 - 09/2008
9	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2024 - 01/2015
9	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 05/2013
7	Neoplasms (Cancer) 01/2024 - 01/2013
7	Inflammation (Inflammations) 01/2024 - 09/2008
7	Relapsing-Remitting Multiple Sclerosis 01/2023 - 03/2016
6	Seizures (Absence Seizure) 01/2024 - 09/2017
6	Glioma (Gliomas) 01/2023 - 04/2016
5	Myasthenia Gravis 10/2023 - 01/2019
5	Autoimmune limbic encephalitis 01/2023 - 01/2020
4	Epilepsy (Aura) 01/2023 - 09/2017
4	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 11/2021 - 07/2017
3	Cerebellar Ataxia (Dysmetria) 01/2023 - 07/2012
3	Disease Progression 01/2023 - 09/2008
3	Central Nervous System Diseases (CNS Diseases) 07/2012 - 09/2009
2	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2023 - 01/2023
2	Ataxia (Dyssynergia) 01/2023 - 01/2023
2	Infections 11/2021 - 01/2013
2	Lymphoma (Lymphomas) 12/2019 - 01/2018
2	Sepsis (Septicemia) 01/2019 - 01/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2016 - 09/2008
1	Gait Ataxia 01/2024
1	Cognitive Dysfunction 01/2024
1	Subdural Hematoma (Subdural Hemorrhage) 12/2023
1	Pain (Aches) 01/2023
1	Gliosis 01/2023
1	Thymoma (Thymic Carcinoma) 01/2023
1	Tremor (Tremors) 01/2023
1	Sleep Wake Disorders 01/2023
1	Myoclonus (Nocturnal Myoclonus) 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023
1	Medically Unexplained Symptoms 01/2023
1	Movement Disorders (Movement Disorder) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Neuromyelitis Optica (Devic's Disease) 12/2022
1	Demyelinating Diseases (Demyelinating Disease) 12/2022
1	Dizziness (Lightheadedness) 10/2022
1	Headache (Headaches) 10/2022
1	Hyponatremia 10/2022
1	Nausea 10/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 03/2022
1	Blood Vessel Dissection 03/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2022
1	Hemorrhagic Stroke 03/2022
1	Hemorrhage 03/2022
1	COVID-19 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 12/2021
1	Neuroinflammatory Diseases 11/2021
1	Brain Diseases (Brain Disorder) 11/2021
1	Virus Diseases (Viral Diseases) 11/2021
1	Central Nervous System Infections (Central Nervous System Infection) 11/2021
1	Temporal Lobe Epilepsy 10/2021

Drug/Important Bio-Agent (IBA)

16	AutoantibodiesIBA 01/2024 - 08/2016
15	AntibodiesIBA 01/2023 - 07/2012
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2016
10	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 04/2016
9	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2023 - 04/2016
8	Leucine (L-Leucine)FDA Link 01/2023 - 04/2016
6	AntigensIBA 01/2023 - 05/2013
6	Alemtuzumab (Campath)FDA Link 03/2022 - 03/2016
4	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2015
3	Rituximab (Mabthera)FDA Link 01/2022 - 07/2017
3	Surface Antigens (Surface Antigen)IBA 01/2020 - 05/2013
2	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 03/2024 - 01/2023
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 11/2021
2	Cholinergic ReceptorsIBA 01/2023 - 01/2019
2	Aminobutyrates (Aminobutyric Acid)IBA 03/2022 - 06/2016
2	ocrelizumabIBA 01/2022 - 01/2022
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 04/2016
2	Immunoglobulin G (IgG)IBA 01/2019 - 08/2016
2	Immunoglobulins (Immunoglobulin)IBA 07/2018 - 01/2018
2	EnzymesIBA 11/2016 - 01/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2016 - 03/2016
2	CationsIBA 11/2014 - 01/2012
2	Glutamic Acid (Glutamate)FDA Link 10/2013 - 09/2008
2	Potassium Channels (Potassium Channel)IBA 09/2009 - 12/2008
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Complement System Proteins (Complement)IBA 10/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 01/2023
1	anti-CASPR2 autoantibodyIBA 01/2023
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Myelin-Oligodendrocyte GlycoproteinIBA 12/2022
1	Sodium Channel BlockersIBA 10/2022
1	eslicarbazepine acetateIBA 10/2022
1	VaccinesIBA 01/2022
1	eculizumab FDA Link 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021
1	Edrophonium (Tensilon)FDA LinkGeneric 01/2021

Therapy/Procedure

12	Therapeutics 01/2023 - 09/2009
9	Immunotherapy 01/2024 - 05/2013
1	Electrodes (Electrode) 12/2023
1	Thymectomy 01/2023
1	Activities of Daily Living (ADL) 01/2023
1	Immunomodulation 01/2022